MDCX· Health Care› Drug Manufacturers - General

Medicus Pharma Ltd.

Stage 4 · Declining · week 10

As of Oct 22, 2026, Medicus Pharma is in Stage 4, the downtrend phase, now in week 10 (since Aug 17, 2026). It closed at $2.62, 98.1% below its 52-week high and below its 200-day average, which is falling.

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. More about the company

$2.62

-0.38% today

$3.8M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is MDCX early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2024-11-14 → 2026-10-22

S? 42w

S4 31w

S4 10w

2024-11-142026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 42w → S4 8w → S1 5w → S4 31w → S1 5w → S4 10w current

Total tracked: 101 weeks across 6 stage runs.

MDCX among Drug Manufacturers - General21st of 21 by relative strength

All 21 →

Stocks in Drug Manufacturers - General ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	MRKMerck & Company, Inc.	Stage 2 · wk 16	92	−0.6%
2	BIIBBiogen Inc.	Stage 2 · wk 21	92	+11.6%
3	LLYEli Lilly and Company	Stage 2 · wk 1	90	+13.5%
4	AMGNAmgen Inc.	Stage 2 · wk 16	87	+10.1%
5	OGNOrganon & Co.	Stage 2 · wk 23	87	+0.1%
6	BMYBristol-Myers Squibb Company	Stage 3 · wk 1	85	+4.1%
7	JNJJohnson & Johnson	Stage 2 · wk 16	83	−0.6%
8	PFEPfizer, Inc.	Stage 2 · wk 8	77	+7.9%
…21	MDCXMedicus Pharma Ltd.	Stage 4 · wk 10	4	−67.0%

vs 52W High

-98.1%

$2.62 lo$135.00 hi

98.1% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 10

1w13w26w

Week 10, established downtrend

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-89.5%

200 DMA: $25.04 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.35x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-67.0%

-85.8%

-84.2%

YTD

-96.7%

-97.8%

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-10-22S4

Wk 10 · Vol 0.35x

2026-10-21S4

Wk 10 · Vol 0.23x

2026-10-20S4

Wk 10 · Vol 0.75x

2026-10-19S4

Wk 9 · Vol 0.75x

2026-10-16S4

Wk 9 · Vol 0.23x

2026-10-15S4

Wk 9 · Vol 1.71x

2026-10-14S4

Wk 9 · Vol 0.58x

2026-10-13S4

Wk 9 · Vol 0.56x

2026-10-12S4

Wk 8 · Vol 1.05x

2026-10-09S4

Wk 8 · Vol 3.12x

2026-10-08S4

Wk 8 · Vol 2.75x

2026-10-07S4

Wk 8 · Vol 0.92x

Moving averages & range

50 DMA

$8.69

200 DMA

$25.04

52W High

$135.00

52W Low

$2.62

5D Low

$2.62

Resistance levels (recent highs)

20d High

$8.35

60d High

$17.70

120d High

$24.40

250d High

$135.00

Next resistance

+218.7%

to 20d High

ROE

-7446.1%

Profit margin 0.0%

Dividend Yield

0.00%

P/B -1.8

Medicus Pharma: quick answers

What stage is Medicus Pharma in?

As of Oct 22, 2026, Medicus Pharma (MDCX) is in Stage 4, the downtrend phase. It entered Stage 4 on Aug 17, 2026 and is in week 10. What the four stages mean

Is Medicus Pharma in an uptrend?

No. Medicus Pharma is in a Stage 4 downtrend. It trades 89.5% below its 200-day average, which is falling.

How far is Medicus Pharma from its 52-week high?

Medicus Pharma closed at $2.62 on Oct 22, 2026, 98.1% below its 52-week high of $135.00. Its 52-week low is $2.62.

How has Medicus Pharma performed over the past year?

As of Oct 22, 2026, Medicus Pharma is down 97.8% over the past year and down 96.7% so far in 2026.

Which sector and industry is Medicus Pharma in?

Medicus Pharma is in the Drug Manufacturers - General industry, part of the Health Care sector.

About this companyHealth Care· Drug Manufacturers - General

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.